105 related articles for article (PubMed ID: 10419556)
1. Inhibition of protein kinases by balanol: specificity within the serine/threonine protein kinase subfamily.
Setyawan J; Koide K; Diller TC; Bunnage ME; Taylor SS; Nicolaou KC; Brunton LL
Mol Pharmacol; 1999 Aug; 56(2):370-6. PubMed ID: 10419556
[TBL] [Abstract][Full Text] [Related]
2. Molecular design and biological activity of potent and selective protein kinase inhibitors related to balanol.
Koide K; Bunnage ME; Gomez Paloma L; Kanter JR; Taylor SS; Brunton LL; Nicolaou KC
Chem Biol; 1995 Sep; 2(9):601-8. PubMed ID: 9383464
[TBL] [Abstract][Full Text] [Related]
3. Differential and selective inhibition of protein kinase A and protein kinase C in intact cells by balanol congeners.
Gustafsson AB; Brunton LL
Mol Pharmacol; 1999 Aug; 56(2):377-82. PubMed ID: 10419557
[TBL] [Abstract][Full Text] [Related]
4. Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases.
Hardianto A; Yusuf M; Liu F; Ranganathan S
BMC Bioinformatics; 2017 Dec; 18(Suppl 16):572. PubMed ID: 29297286
[TBL] [Abstract][Full Text] [Related]
5. Balanol analogues probe specificity determinants and the conformational malleability of the cyclic 3',5'-adenosine monophosphate-dependent protein kinase catalytic subunit.
Akamine P; Madhusudan ; Brunton LL; Ou HD; Canaves JM; Xuong NH; Taylor SS
Biochemistry; 2004 Jan; 43(1):85-96. PubMed ID: 14705934
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of the potent natural product inhibitor balanol in complex with the catalytic subunit of cAMP-dependent protein kinase.
Narayana N; Diller TC; Koide K; Bunnage ME; Nicolaou KC; Brunton LL; Xuong NH; Ten Eyck LF; Taylor SS
Biochemistry; 1999 Feb; 38(8):2367-76. PubMed ID: 10029530
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling Catalytic and Binding Functions in the Cyclic AMP-Dependent Protein Kinase A.
Kim J; Li G; Walters MA; Taylor SS; Veglia G
Structure; 2016 Mar; 24(3):353-63. PubMed ID: 26833386
[TBL] [Abstract][Full Text] [Related]
8. The Protein kinase inhibitor balanol: structure-activity relationships and structure-based computational studies.
Pande V; Ramos MJ; Gago F
Anticancer Agents Med Chem; 2008 Aug; 8(6):638-45. PubMed ID: 18690827
[TBL] [Abstract][Full Text] [Related]
9. DNA repair protein O6-alkylguanine-DNA alkyltransferase is phosphorylated by two distinct and novel protein kinases in human brain tumour cells.
Mullapudi SR; Ali-Osman F; Shou J; Srivenugopal KS
Biochem J; 2000 Oct; 351 Pt 2(Pt 2):393-402. PubMed ID: 11023825
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and protein kinase C inhibitory activities of acyclic balanol analogs that are highly selective for protein kinase C over protein kinase A.
Defauw JM; Murphy MM; Jagdmann GE; Hu H; Lampe JW; Hollinshead SP; Mitchell TJ; Crane HM; Heerding JM; Mendoza JS; Davis JE; Darges JW; Hubbard FR; Hall SE
J Med Chem; 1996 Dec; 39(26):5215-27. PubMed ID: 8978850
[TBL] [Abstract][Full Text] [Related]
11. Computational analysis of PKA-balanol interactions.
Wong CF; Hünenberger PH; Akamine P; Narayana N; Diller T; McCammon JA; Taylor S; Xuong NH
J Med Chem; 2001 May; 44(10):1530-9. PubMed ID: 11334563
[TBL] [Abstract][Full Text] [Related]
12. Diverse dynamics features of novel protein kinase C (PKC) isozymes determine the selectivity of a fluorinated balanol analogue for PKCε.
Hardianto A; Khanna V; Liu F; Ranganathan S
BMC Bioinformatics; 2019 Feb; 19(Suppl 13):342. PubMed ID: 30717648
[TBL] [Abstract][Full Text] [Related]
13. Designing specific protein kinase inhibitors: insights from computer simulations and comparative sequence/structure analysis.
Gould C; Wong CF
Pharmacol Ther; 2002; 93(2-3):169-78. PubMed ID: 12191609
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.
Lai YS; Mendoza JS; Jagdmann GE; Menaldino DS; Biggers CK; Heerding JM; Wilson JW; Hall SE; Jiang JB; Janzen WP; Ballas LM
J Med Chem; 1997 Jan; 40(2):226-35. PubMed ID: 9003521
[TBL] [Abstract][Full Text] [Related]
15. STO-609, a specific inhibitor of the Ca(2+)/calmodulin-dependent protein kinase kinase.
Tokumitsu H; Inuzuka H; Ishikawa Y; Ikeda M; Saji I; Kobayashi R
J Biol Chem; 2002 May; 277(18):15813-8. PubMed ID: 11867640
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of serine/threonine kinases.
Lee JC; Adams JL
Curr Opin Biotechnol; 1995 Dec; 6(6):657-61. PubMed ID: 8527836
[TBL] [Abstract][Full Text] [Related]
17. An organoiron approach to the benzophenone appendage of the protein kinase C inhibitor balanol.
Storm JP; Andersson CM
Org Lett; 1999 Nov; 1(9):1451-3. PubMed ID: 10825993
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and protein kinase inhibitory activity of balanol analogues with modified benzophenone subunits.
Lampe JW; Biggers CK; Defauw JM; Foglesong RJ; Hall SE; Heerding JM; Hollinshead SP; Hu H; Hughes PF; Jagdmann GE; Johnson MG; Lai YS; Lowden CT; Lynch MP; Mendoza JS; Murphy MM; Wilson JW; Ballas LM; Carter K; Darges JW; Davis JE; Hubbard FR; Stamper ML
J Med Chem; 2002 Jun; 45(12):2624-43. PubMed ID: 12036372
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Account on the Synthesis of (-)-Balanol and its Analogues.
Ahmad S; Akhtar R; Zahoor AF
Curr Org Synth; 2022; 19(1):56-85. PubMed ID: 34370642
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.
Qin L; Sankaran B; Aminzai S; Casteel DE; Kim C
J Biol Chem; 2018 Jul; 293(28):10985-10992. PubMed ID: 29769318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
